News
World’s first platform combining medical expertise and musical innovation launched
A unique platform that uses the universal language of music to help people better understand diabetes and other healthcare concepts has been launched to mark World Diabetes Day. Developed by Dr Step...
New survey highlights emotional and professional challenges faced by people with diabetes
Individuals living with diabetes are at higher risk of experiencing poor wellbeing and negative work experiences, new survey findings from Roche have shown ahead of World Diabetes Day. More than 16,00...
MPs praise Sheffield’s pioneering approach to diabetes care
MPs have described a pioneering one-stop diabetes screening service as the future of how diabetes care should be provided during a recent visit to the Northern General Hospital. Tom Gordon, Liberal D...
Teplizumab will keep UK at forefront of diabetes care, expert says
The first ever immunotherapy for type 1 diabetes is critical for keeping the UK at the forefront of diabetes care, a top consultant has said. Professor Parth Narendran, from the University of Birmingh...
Paediatric diabetes team come out top
The paediatric diabetes team at Good Hope Hospital has topped the table in a national audit which looks at children’s diabetes care. The National Paediatric Diabetes Audit (NPDA) measures the health o...
CamDiab launches iPhone companion feature for CamAPS FX
The digital health and medical device company behind the CamAPS FX app has announced the launch of its iPhone companion feature, enabling iPhone users to remotely monitor glucose and insulin data for ...
Experts call for universal screening to spot type 1 diabetes early
The European Association for the Study of Diabetes (EASD) is urging health systems to introduce population-wide screening for type 1 diabetes in young children, starting between ages two and four. Mos...
Vertex shares additional updates on zimislecel in type 1 diabetes
Vertex Pharmaceuticals shared an additional look at data from the Phase 1/2 FORWARD clinical trial, investigating the use of zimislecel for the treatment of type 1 diabetes complicated by severe hypog...
Orforglipron taken orally once daily leads to significant body weight loss
New research presented at the Annual Meeting of the European Association for the Study of Diabetes 2025 shows that daily treatment with the new once-daily GLP-1 agonist orforglipron results in substan...